Why the study?
Does substituting apoB-48 with apoB-100 improve the type-III hyperlipoproteinemia phenotype in Apoe(2/2) mice?
Does substituting apoB-48 with apoB-100 improve the type-III hyperlipoproteinemia phenotype in Apoe(2/2) mice?
In a mouse model of type-III hyperlipoproteinemia, substituting apoB-48 with apoB-100 did not improve the phenotype because the two apolipoproteins differentially influence lipoprotein catabolism.
Answers are grounded in this paper and cite their sources.
Does not support apoB isoform substitution for type III hyperlipoproteinemia; leaves open differential apoB effects on human lipoprotein catabolism.
Apolipoprotein E (apoE) is essential for the clearance of plasma chylomicron and VLDL remnants. The human APOE locus is polymorphic and 5-10% of APOE*2 homozygotes exhibit type-III hyperlipoproteinemia (THL), while the remaining homozygotes have less than normal plasma cholesterol. In contrast, mice expressing APOE*2 in place of the mouse Apoe (Apoe(2/2) mice) are markedly hyperlipoproteinemic, suggesting a species difference in lipid metabolism (e.g., editing of apolipoprotein B) enhances THL development. Since apoB-100 has an LDLR binding site absent in apoB-48, we hypothesized that the Apoe(2/2) THL phenotype would improve if all Apoe(2/2) VLDL contained apoB-100. To test this, we crossed Apoe(2/2) mice with mice lacking the editing enzyme for apoB (Apobec(-/-)). Consistent with an increase in remnant clearance, Apoe(2/2). Apobec(-/-) mice have a significant reduction in IDL/LDL cholesterol (IDL/LDL-C) compared with Apoe(2/2) mice. However, Apoe(2/2).Apobec(-/-) mice have twice as much VLDL triglyceride as Apoe(2/2) mice. In vitro tests show the apoB-100-containing VLDL are poorer substrates for lipoprotein lipase than apoB-48-containing VLDL. Thus, despite a lowering in IDL/LDL-C, substituting apoB-48 lipoproteins with apoB-100 lipoproteins did not improve the THL phenotype in the Apoe(2/2).Apobec(-/-) mice, because apoB-48 and apoB-100 differentially influence the catabolism of lipoproteins.
No takes yet. Share an insight, caveat, or question.
Hinsdale et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: